JTO Clinical and Research Reports

SJR Rank #1,933H-index: 31SJR: 1.708Best quartile: Q1Open AccessAPC: US$2,000Listed in DOAJ

Journal website: aims, scope and author guidelines

Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

Subject Categories

OncologyQ1
Pulmonary and Respiratory MedicineQ1

Areas: Medicine

Most published research topics

Lung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer ResearchRadiomics and Machine Learning in Medical ImagingGlobal Cancer Incidence and ScreeningMyasthenia Gravis and Thymoma

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

2666-3643

SJR Best Quartile

Region

Northern America

Citations per Document (2 years)

3.32

References per Document

25.26

Coverage

2020-2026

Scope

JTO Clinical and Research Reports is the official open access journal of the International Association for the Study of Lung Cancer. It aims to complement the Journal of Thoracic Oncology by offering authors a gold open access publication option and publishing the following article types in particular: Phase I trials Well performed single-arm phase II trials Subset analyses of published trials Impactful retrospective Studies Database analysis Large institutional series High-quality case reports Region-specific clinical trials Subspecialty thoracic oncology studies Selected high-quality meeting reports As an open access journal with no subscription charges, JTO CRR requires authors to pay a fee to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone

Metrics from SCImago Journal Rank 2025. View on SCImago